Michael A. Choti, MD, MBA, Banner MD Anderson, cochaired the second annual Advancing Value-Based Oncology Care meeting and shared insights into the goals of this year's event and value-based medicine as a whole.
On June 20, 2024, Michael A. Choti, MD, MBA, Banner MD Anderson, co-chaired the second annual Advancing Value-Based Oncology Care meeting in Phoenix, Arizona. In an interview with The American Journal of Managed Care®, Choti touched upon the goals of this year’s event, as well as some of the crucial challenges and considerations of value-based oncology care.
This transcript has been lightly edited
Transcript
How would you characterize the goals of, or biggest takeaways from, this second annual Advancing Value-Based Oncology Care event?
Oncology is challenging. It's expensive, it requires integration. I think a message here that we've learned is really the importance of the complexity of [value-based care], of managing cancer care in an integrated way, controlling costs. So, this meeting really highlighted how others are doing it. At Banner MD Anderson, we're an organization that's clearly moving in that direction; we showcased the direction that we're going in in this space, and I think it really made for a very exciting symposium again this year.
In your opinion, what are the most critical components that need to be in place for value-based oncology care to be successfully implemented?
The critical components to move toward value-based care, as you've heard in this conference as well, is really the creation of integrated multidisciplinary cancer management; informatics and good analytics in order to really understand cost, utilization, best practice; as well as opportunities to address disparities and care for everyone.
How can health care systems balance the cost of innovative cancer treatments with the principles of value-based care?
I think one of the challenges of cancer care is really balancing the cost of cancer care with the principles of value-based medicine. This is a challenge. How can we address this, and what are the ways we can? I think one is to leverage technologies: predictive analytics, information technology. Artificial intelligence, I think this will be an area that will support the direction of providing high-quality cancer care in the context of value-based care.
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More